Cite
HARVARD Citation
Layman, R. et al. (2022). Clinical outcomes and Oncotype DX Breast Recurrence Score® in early‐stage BRCA‐associated hormone receptor‐positive breast cancer. Cancer medicine. pp. 1474-1483. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Layman, R. et al. (2022). Clinical outcomes and Oncotype DX Breast Recurrence Score® in early‐stage BRCA‐associated hormone receptor‐positive breast cancer. Cancer medicine. pp. 1474-1483. [Online].